Phase I/II a clinical trial of PL265 in patients with ocular pain.
Phase of Trial: Phase I/II
Latest Information Update: 12 May 2017
At a glance
- Drugs PL 265 (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 12 May 2017 This trial is expected to begin in 2018, according to a Pharmaleads media release.
- 11 May 2017 New trial record